Topical fosaprepitant for the treatment of ocular pain and inflammation
Open Access
- 25 November 2023
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 32, 101964
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Fibromyalgia syndrome and the eye—A reviewSurvey of Ophthalmology, 2021
- Ocular Surface Pain: A Narrative ReviewOphthalmology and Therapy, 2020
- NSAID-induced corneal melt: Clinical importance, pathogenesis, and risk mitigationSurvey of Ophthalmology, 2020
- Pain, Dryness, and Itch Sensations in Eye Surface Disorders Are Defined By a Balance Between Inflammation and Sensory Nerve InjuryCornea, 2019
- Substance P Modulation of Human and Murine Corneal NeovascularizationInvestigative Ophthalmology & Visual Science, 2018
- Diagnosis and Treatment of Ocular Pain: the Ophthalmologist’s PerspectiveCurrent Ophthalmology Reports, 2017
- Growth inhibition of formed corneal neovascularization following Fosaprepitant treatmentActa Ophthalmologica, 2017
- Aprepitant and Fosaprepitant: A 10-Year Review of Efficacy and SafetyThe Oncologist, 2015
- Diagnosis and management of neurotrophic keratitisClinical Ophthalmology, 2014
- Corticosteroids and Glaucoma RiskDrugs & Aging, 1999